APPLIED ENERGETICS, INC.

AERG
Country: United StatesPrice: $0.86Market Cap: $193.0M

Investment snapshot

6%positive consensus
Scored 1d ago

Positive

1

BUY / PASS

Neutral / negative

1 / 14

NEUTRAL / FAIL

Median fair value

—

No comparable estimates

Models with upside

0 / 17

Positive margin of safety

Strongest signal

8 of 12 pass — Graham, Buffett, Lynch +1 more object

Key risk

No clean pass — all 16 investors flag at least one profitability criterion

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILFAIL · Rank #2699 (Top 87.1%)PASSFAILFAILFAILFAILFAILFAILFAILFAILFAILFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Financial Basis

Annual history · FY 2025 · Balance sheet at 2026-06-30

Latest source filing: 2026-08-13

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-30

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-06-30 · TTM ended 2026-06-30 vs 2025-06-30 · TTM ended 2026-06-30

Latest source filing: 2026-08-13

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-30

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-30

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Market data at 2026-11-01

Latest source filing: 2026-08-13

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30

Latest source filing: 2026-08-13

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-03-30

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · Balance sheet at 2026-06-30

Latest source filing: 2026-08-13

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-30

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Market data at 2026-11-01

Latest source filing: 2026-08-13

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-06-30

Latest source filing: 2026-08-13

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-30

Score computed: 2026-11-14

TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-08-13

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-06-30

Latest source filing: 2026-08-13

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-06-30

Latest source filing: 2026-08-13

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-06-30 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-08-13

Score computed: 2026-11-14

Where It Passes

  • Debt & Leverage67% pass✓ 11✗ 4▾

    8 of 12 pass — Graham, Buffett, Lynch +1 more object

    LT Debt vs Net Current Assets
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 0.01, IC: -7254.7x
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity0.09
    ✓Lynch< 0.33
    Cash - Long-term Debt
    ✗LynchPositive preferred
    LT Debt / Total Assets Change0.00% -> 0.00%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities1.58
    ✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity0.09
    ✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
    Debt Levels0.09
    ✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=-7254.7x, D/EBITDA=N/A
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity0.09
    ✓Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-0.0927; #1242/4210 (top 29.5%)
    ✓AsnessTop 30% of eligible cross-section

Where It Falls Short

  • Profitability0% pass✓ 4✗ 31▾

    No clean pass — all 16 investors flag at least one profitability criterion

    Positive EPS (10 years)0/22 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)0/22 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)-654.6%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)-3233.6% (latest)
    ✓BuffettStable or rising over 10 years
    Free Cash Flow Proxy$-15.8M
    ✗BuffettPositive and growing
    Earnings Variance (10-yr CoV)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROE-735.2%
    ✗Lynch> 15%
    EBIT / Enterprise Value-8.0%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-8.0%, ROC=-1555.1%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets-164.07%
    ✗PiotroskiROA > 0
    ROA Change YoY-443.05% -> -164.07% (delta: +278.97%)
    ✓PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=-101.91%, ROA=-164.07%
    ✓PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY39.0% -> 54.0%
    ✓PiotroskiImproved YoY
    Pre-Tax Income / Revenue-3221.1%
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity-735.2%
    ✗Dreman> 12%
    Margin of SafetyP/B=25.5x
    ✗PabraiP/B < 1.5 or P/E < 15
    Return on Equity-995.5% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic Value
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency0/16 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue-3233.6%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity-735.2%
    ✗Ackman>= 15%
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend-281.1% (2023) -> -3233.6% (2025)
    ✗TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendgross margin 75.8% -> 54.0%, operating margin -281.1% -> -3233.6%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization-8.33%; #4092/6340 (top 64.5%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets+2.75%; #3223/3702 (top 87.1%)
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity-735.23%; #5128/5226 (top 98.1%)
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-1.2757; #5344/5884 (top 90.8%)
    ✗AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years0/10 years positive
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Valuation0% pass✓ 1✗ 27▾

    No clean pass — all 13 investors flag at least one valuation criterion

    Price / 3-yr avg EPS
    ✗Graham<= 15x
    Price-to-Book Ratio25.5x
    ✗Graham<= 1.5x
    P/E x P/B
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value-8.0%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-8.0%, ROC=-1555.1%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)N/A (negative CFPS)
    ✗Dreman< 8x
    Price / Book Value per Share25.5x
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessOE Yield=-8.2%
    ✗MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldFCF Yield=-5.4%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/B=25.5x
    ✗MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic Value
    ✗Marks>= 20% below intrinsic value
    Price / FCF per ShareN/A (negative FCF)
    ✗Ackman<= 25
    Price vs. Trailing Low122% of trailing low ($0.70)
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization-8.33%; #4092/6340 (top 64.5%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+0.0113; #5180/6449 (top 80.3%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per Share25.46x
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change+278.0%
    ✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+0.0024; #4982/5247 (top 94.9%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization-5.39%; #3007/4519 (top 66.5%)
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date-36.30%; #4674/6202 (top 75.4%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Cash Flow0% pass✓ 1✗ 11▾

    No clean pass — all 10 investors flag at least one cash flow criterion

    Free Cash Flow Proxy$-15.8M
    ✗BuffettPositive and growing
    FCF Positive and Growing$-10.4M
    ✗LynchPositive and growing
    Operating Cash Flow$-9.2M
    ✗PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=-101.91%, ROA=-164.07%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)N/A (negative CFPS)
    ✗Dreman< 8x
    P/E or FCF YieldFCF Yield=-5.4%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive0/9 years FCF positive
    ✗MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap-5.4%
    ✗Ackman>= 4%
    Price / FCF per ShareN/A (negative FCF)
    ✗Ackman<= 25
    Positive Operating Cash Flow frequency0/16 years positive
    ✗SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$-10.4M
    ✗Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization-5.39%; #3007/4519 (top 66.5%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Growth0% pass✓ 2✗ 11▾

    No clean pass — all 8 investors flag at least one growth criterion

    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthN/A (no inventory)
    ✓LynchInventory growth < Revenue growth
    EPS Growth Direction
    ✗DremanPositive over recent years
    EPS CAGR
    ✗Dreman> 5% annualized
    Positive Net Income Frequency0/16 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth-7.8%
    ✗Ackman>= 5%
    Positive EPS Growth Frequency
    ✗AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendgross margin 75.8% -> 54.0%, operating margin -281.1% -> -3233.6%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR21.3%
    ✓SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
  • Verdicts6% pass✓ 1✗ 15▾

    Split decision: 14 FAIL · 1 PASS · 1 NEUTRAL

    Overall verdict
    ✗GrahamFAIL (0/9)✗BuffettFAIL (1/9)✗LynchFAIL (2/7)✗GreenblattRank #2699✓PiotroskiPASS (F-Score 5)✗DremanFAIL (2/11)✗MungerFAIL (1/4)✗PabraiFAIL (0/3)✗AkreFAIL (1/6)✗MarksFAIL (0/5)✗AckmanFAIL (1/9)✗TempletonFAIL (2/8)✗SleepFAIL (1/6)✗AsnessFAIL (Rank #2324/2370 (Top 98.1%))✗NeffFAIL (1/6)✗SchlossFAIL (3/7)•OshaughnessyNEUTRAL (Not ranked)
  • Efficiency13% pass✓ 2✗ 9▾

    7 of 8 flag AERG's efficiency — Graham, Buffett, Greenblatt +4 more

    Current Ratio1.58
    ✗Graham>= 2.0
    ROIC (3-5 yr avg)-1650.5%
    ✗Buffett> 10%
    ROIC - WACC-1660.5%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)-1555.1%
    ✗Greenblatt> 25%
    Current Ratio Change YoY0.91 -> 8.29
    ✓PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY1.17x -> 0.05x
    ✗PiotroskiImproved YoY
    Current Assets / Current Liabilities1.58
    ✓Dreman> 1.5
    Return on Invested Capital-534.9%
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=-360.7%; FY2024: ROIC=-1647.4%; FY2025: ROIC=-155.0%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROICN/A (non-positive net income)
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)0/5 years above 12% (latest -155.0%)
    ✗SleepROIC > 12% in a majority of years

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Electronic Equipment
SIC Sector: Measuring & Medical Instruments
Size: Micro Cap($193.0M)
Revenue: $461727.00-81.0% YoY
Net Income: $14.9M-62.1% YoY

Financial Snapshot

Operating Margin-3233.6%
Return on Equity-196.7%
Debt / Equity0.01
Current Ratio8.29
EPS (Diluted)$-0.07
Shares Retired−4.7% / −5.9% 2y

Shareholder Return

Fiscal 2025

Issued 4.7% of shares last year, 5.9% issued over two.

Buybacks
—
Dividends
—

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-09-30

2025-10-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: revenue, net income, operating income, gross profit, ebit, pre tax income, operating cash flow, depreciation amortization, capex.

Q3 FY 2026

2026-07-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, depreciation amortization, capex.

Q2 FY 2026

2026-04-01 – 2026-06-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, depreciation amortization, capex.

Q1 FY 2026

2026-01-01 – 2026-03-31

Sources
FY 2025
Sources
  • 10-K · 2026-03-30
FY 2024
Sources
  • 10-K · 2025-03-28
FY 2023
Sources
  • 10-K · 2024-03-26
FY 2022
Sources
  • 10-K · 2023-03-30
FY 2021
Sources
  • 10-K · 2022-03-31
Market Cap$193.0Mcurrent------$321.0Mest.$210.7Mest.$403.7Mest.$432.6Mest.$400.7Mest.
Revenue--$106.0K↓3%$62.0K↓12%--$461.7K↓81%$2.4M↓8%$2.6M↑101%$1.3M--
Operating Income-$16.5M↓27%-$4.3M↓8%-$4.3M↓14%-$3.8M↓23%-$14.9M↓63%-$9.2M↓24%-$7.4M↓28%-$5.8M↓5%-$5.5M
Net Income-$16.4M↓26%-$4.3M↓8%-$4.3M↓13%-$3.8M↓23%-$14.9M↓62%-$9.2M↓25%-$7.4M↓27%-$5.8M↓6%-$5.4M
EPS (Diluted)--$-0.02$-0.02$-0.02$-0.07↓75%$-0.04↓33%$-0.03$-0.03$-0.03
Gross Margin—87.2%↑71%65.2%↑101%—54.0%↑38%39.0%↓49%75.8%↓1%76.6%—
Operating Margin—-4061.3%↓11%-6934.9%↓29%—-3233.6%↓755%-378.2%↓35%-281.1%↑36%-441.2%—
ROE1534.8%↓14%———-196.7%↑92%-2336.1%↓415%-453.7%↓338%-103.5%↑43%-182.8%
Total Debt$137.0K↑43%$137.0K↑43%$202.6K↑41%--$48.0K↑1%$47.3K$0↓100%$400.0K↓61%$1.0M
Shareholders' Equity-$1.1M↓46%-$1.1M↓46%$2.2M↑29%$5.1M↑19%$7.6M↑1825%$392.7K↓76%$1.6M↓71%$5.6M↑88%$3.0M
Current Ratio0.52↓74%0.52↓74%1.58↑29%4.96↓16%8.29↑814%0.91↓59%2.20↓73%8.04↑207%2.62
Debt / Equity-0.13↑2%-0.13↑2%0.09↑9%—0.01↓95%0.120.00↓100%0.07↓79%0.35
Operating Cash Flow-$10.7M↓34%-$3.0M↓19%-$2.8M↓18%-$2.3M↓33%-$9.2M↓81%-$5.1M↓48%-$3.5M↑12%-$3.9M↓22%-$3.2M
Free Cash Flow-$10.9M↓18%-$3.0M↓19%-$2.9M↑17%-$2.3M↓27%-$10.5M↓102%-$5.2M↓36%-$3.8M↑5%-$4.0M↓17%-$3.4M

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Electronic Equipment

AERG vs Peers — Financial Grading

Revenue$461727.00Bottom 25%
Net Income$14.9MBottom 25%
ROE-196.7%Bottom 25%
D/E0.01Top 25%
Op. Margin-3233.6%Bottom 25%
Curr. Ratio8.29Top 25%
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
NVIDIA CORPNVDA$3.93T$162.85$215.9B$120.1B76.3%0.0560.4%3.913/96/93/71/3F-Score 45/11
INTEL CORPINTC$317.1B$59.66$52.9B$267.0M-0.2%0.41-4.2%2.023/90/91/70/3F-Score 63/11
TEXAS INSTRUMENTS INCTXN$277.4B$303.60$17.7B$5.0B30.7%0.8634.1%4.356/95/93/71/3F-Score 77/11
ANALOG DEVICES INCADI$192.8B$397.97$11.0B$2.3B6.7%0.2426.6%2.192/93/94/71/3F-Score 84/11
Motorola Solutions, Inc.MSI$87.8B$531.20$11.7B$2.2B89.4%3.4925.6%1.042/94/93/71/3F-Score 65/11
L3HARRIS TECHNOLOGIES, INC. /DE/LHX$50.7B$272.35—$1.6B8.2%0.57—1.192/92/93/71/3F-Score 73/11
NOKIA CORPNOK$45.7B$8.07$23.4B$764.7M3.1%0.164.4%1.582/91/93/71/3F-Score 53/11
ERICSSON LM TELEPHONE COERIC$34.2B$10.56$25.7B$3.1B26.0%0.3016.3%1.292/95/95/73/3F-Score 77/11